This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whyte, T.
Right arrow Articles by Escribà, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whyte, T.
Right arrow Articles by Escribà, J. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2000, p. 3131-3132, Vol. 38, No. 8
0095-1137/00/$04.00+0

LETTERS TO THE EDITOR

Evaluation of the BACTEC MGIT 960 and MB BAC/T Systems for Routine Detection of Mycobacterium tuberculosis


    LETTER

Dr. Alcaide and colleagues have recently reported an evaluation of the BACTEC MGIT 960 (Becton Dickinson) and MB/BacT (Organon Teknika) systems for recovery of mycobacteria from clinical specimens (1). We have recently completed a similar evaluation at the University College Hospital Galway.

Our evaluation was conducted on 493 specimens submitted between November 1999 and February 2000. There were 365 respiratory tract specimens and 128 nonrespiratory tract specimens (including pleural fluid, urine, and cerebrospinal fluid). Sputum samples were predigested with an equal volume of Sputasol (Oxoid) following centrifugation at 3,000 × g for 15 min. A slide was prepared from the sediment for microscopy, and the remaining sediment was decontaminated with 4% aqueous NaOH for 20 min followed by neutralization with 14% KH2PO4. Following centrifugation, the sediment was resuspended in approximately 1 ml of neutralization buffer and 0.5 ml of material was inoculated into each of the two systems. Bronchoalveolar lavage specimens were treated in a similar manner. Urine specimens were concentrated by centrifugation, and the deposit was decontaminated with 2.5 ml of 5% sulfuric acid for 30 min. Other contaminated specimens were decontaminated with 4% NaOH followed by neutralization. Slides for microscopy were stained with Auramine O. Antimicrobials were added to the culture vials prior to inoculation (PANTA for BACTEC MGIT 960 and MAS [MB/BACT antibiotic supplement] for MB/BacT). Cultures were incubated for 6 weeks. From positive cultures, a smear was stained by the Ziehl-Neelsen method. Chocolate agar media were inoculated to check for contamination with bacteria other than mycobacteria.

Isolates of mycobacteria were identified by conventional methods (2, 3). In total, 18 isolates (18 in MB/BacT; 16 in BACTEC MGIT 960) of M. tuberculosis were obtained. The 16 specimens positive in both systems were from the respiratory tract and were positive on microscopy. The two isolates detected only in the MB/BacT system after 28 days of incubation were pleural biopsy and pleural fluid specimens (same patient) and were negative on microscopy. These results are consistent with those of Alcaide et al., indicating no significant difference in the isolation rate of M. tuberculosis between the BACTEC MGIT 960 and the MB/BacT systems (1).

Four MOTT (mycobacteria other than M. tuberculosis) isolates (one M. kansasii and three Mycobacterium avium-M. intracellulare) were detected. The M. kansasii isolate was detected only in the BACTEC MGIT 960 system; the M. avium-M. intracellulare isolates were detected in both systems. The numbers of MOTT isolates are small, and we note that Alcaide et al. found that the MB/BacT was significantly better than the BACTEC MGIT 960 at isolating M. kansasii.

The mean times to detection (TTD) of a positive culture of M. tuberculosis were 8.5 days (range, 4 to 23 days) in the BACTEC MGIT 960 system and 13.4 days (range, 2 to 39 days) in the MB/BacT system. This is consistent with the finding of Alcaide et al. that the mean TTD is significantly shorter in the BACTEC MGIT 960 than in the MB/BacT culture system. In this study, the contamination rate was 8.5% in the BACTEC MGIT 960 system, similar to the results described in previous reports (5). The contamination rate of 25% in the MB/BacT culture system is high relative to the results of Alcaide et al. and others (1, 4) and resulted in contamination with staphylococci or streptococci in 5 of 18 (28%) cultures positive for M. tuberculosis. In our experience, both systems are effective in isolating mycobacteria; however, the BACTEC MGIT 960 system is preferable to the MB/BacT system in particular because of lower contamination rates and also because of a superior mean TTD for M. tuberculosis. Since much of the contamination was due to staphylococci and streptococci, it is possible that the routine addition of vancomycin to the MB/BacT system may reduce the contamination rate.


    FOOTNOTES

* Phone: 353 91 544146

Fax: 353 91 524216

E-mail: Martin.Cormican{at}bsi.ie


    REFERENCES

1. Alcaide, R., M. A. Benitez, J. M. Escriba, and R. Martin. 2000. Evaluation of the BACTEC MGIT 960 and MB/BacT systems for recovery of mycobacteria from clinical specimenc and for species identification by DNA AccuProbe. J. Clin. Microbiol. 38:398-401[Abstract/Free Full Text].
2. Collins, C. H., J. M. Grange, and M. D. Yates. 1985. Organization and practice in tuberculosis bacteriology. Butterworth Ltd., London, United Kingdom.
3. Collins, T., and P. N. Levett. 1989. Radiometric studies on the use of selective inhibitors in the identification of Mycobacterium spp. Med. Microbiol. 30:175-181.
4. Roggenkamp, A., M. W. Hornef, A. Masch, B. Aigner, I. B. Autenrieth, and J. Heesemann. 1999. Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J. Clin. Microbiol. 37:3711-3712[Abstract/Free Full Text].
5. Tortoli, E., P. Cichero, C. Piersimoni, M. Tullia Simonetti, G. Gesu, and D. Nista. 1999. Use of the BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J. Clin. Microbiol. 37:3578-3582[Abstract/Free Full Text].
Tom Whyte
Belinda Hanahoe
Tom Collins
Department of Medical Microbiology
University College Hospital Galway
Galway, Ireland
Geraldine Corbett-Feeney
Martin Cormican*
Department of Bacteriology
National University of Ireland
Galway, Ireland


    AUTHORS' REPLY

The findings of Dr. Whyte and colleagues are similar to the results we reported previously for the detection of Mycobacterium tuberculosis by the BACTEC MGIT 960 and MB/BacT systems (1). Although no significant differences in the isolation rate of M. tuberculosis were found by Whyte et al., the MB/BacT system was better at isolating this species (100%) than the BACTEC MGIT 960 system (88.9%). Surprisingly, only two M. tuberculosis isolates were obtained from smear-negative specimens, and they were only recovered in the MB/BacT system. This fact might explain the short mean time to detection observed in this study, especially with the MGIT 960.

The contamination rate was the greatest difference between the study of Whyte et al. and other comparison studies (1, 2, 5). A bacterial overgrowth rate of >= 9% in the MB/BacT system was initially reported when the original antibiotic supplement was used (4). Since 1998, a revised supplement with vancomycin has been introduced by the manufacturer, and it has practically resolved this problem. However, the contamination rates obtained in the study of Whyte et al. are among the highest reported for the MB/BacT system (25%). This wide variation with the results of other studies may reflect the different antibiotic supplement and digestion-decontamination procedure used by the authors. Interestingly, despite the high rate of contamination found by Whyte et al., the MB/BacT system showed a better recovery rate for M. tuberculosis than the MGIT 960 system did. In our experience with 3,823 clinical specimens collected between July 1999 and April 2000, the contamination rate was 4.2% for the MB/BacT system and the percentage of positive cultures was >7.7%. We have followed the conventional N-acetyl-L-cysteine-NaOH digestion-decontamination procedure (3), and the MB/BacT antibiotic supplement was added only to the bottles for culture of nonsterile specimens, as recommended by the manufacturer. Therefore, we think the bacterial overgrowth in the MB/BacT system is not, at present, a significant problem.

In conclusion, both the MGIT 960 and the MB/BacT are efficient systems for the isolation of mycobacteria in a clinical laboratory, which could replace the radiometric method.


    FOOTNOTES

* Phone: 34-93-2607930

Fax: 34-93-2607547

E-mail: falcaide{at}csub.scs.es.


    FOOTNOTES

    REFERENCES

1. Alcaide, F., M. A. Benítez, J. M. Escribà, and R. Martín. 2000. Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. J. Clin. Microbiol. 38:398-401.
2. Hanna, B. A., A. Ebrahimzadeh, L. B. Elliott, M. A. Morgan, S. M. Novak, S. Rusch-Gerdes, M. Acio, D. F. Dunbar, T. M. Holmes, C. H. Rexer, C. Savthyakumar, and A. M. Vannier. 1999. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J. Clin. Microbiol. 37:748-752[Abstract/Free Full Text].
3. Metchock, B. G., F. S. Nolte, and R. J. Wallace, Jr. 1999. Mycobacterium, p. 399-437. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
4. Rohner, P., B. Ninet, C. Metral, S. Emler, and R. Auckenthaler. 1997. Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens. J. Clin. Microbiol. 35:3127-3131[Abstract].
5. Tortoli, E., P. Cichero, C. Piersimoni, M. T. Simonetti, G. Gesu, and D. Nista. 1999. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J. Clin. Microbiol. 37:3578-3582.
Fernando Alcaide*
Miguel Angel Benítez
Rogelio Martín
Servei de Microbiologia
Ciutat Sanitària i Universitària de Bellvitge
C/Feixa Llarga s/n
08907 L'Hospitalet de Llobregat
Barcelona, Spain
Josep M. Escribà
Cap de Drassanes
Institut Catalá de la Salut
Barcelona, Spain


Journal of Clinical Microbiology, August 2000, p. 3131-3132, Vol. 38, No. 8
0095-1137/00/$04.00+0



This article has been cited by other articles:

  • Hillemann, D., Richter, E., Rusch-Gerdes, S. (2006). Use of the BACTEC Mycobacteria Growth Indicator Tube 960 Automated System for Recovery of Mycobacteria from 9,558 Extrapulmonary Specimens, Including Urine Samples. J. Clin. Microbiol. 44: 4014-4017 [Abstract] [Full Text]  
  • Ardito, F., Posteraro, B., Sanguinetti, M., Zanetti, S., Fadda, G. (2001). Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) Automated System for Drug Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 39: 4440-4444 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whyte, T.
Right arrow Articles by Escribà, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whyte, T.
Right arrow Articles by Escribà, J. M.